Benzinga's Top Upgrades By: Benzinga via Benzinga May 09, 2016 at 10:29 AM EDT Analysts at Mizuho upgraded Depomed Inc (NASDAQ: DEPO) from Neutral to Buy. The price target for Depomed has been raised from $18 to ... Read More >> Related Stocks: Capital One Financial Comerica Commscope Holding Company Depomed Inc Fidelity National Information Services Jacobs Engineering Group Paccar Inc